Docoh
Loading...

VIVE Viveve Medical

Viveve Medical, Inc. is a medical technology company focused on women's intimate health. Viveve is committed to advancing new solutions to improve women's overall well-being and quality of life. The internationally patented Viveve® System incorporates Cryogen-cooled Monopolar Radiofrequency technology to uniformly deliver volumetric heating while gently cooling surface tissue to generate neocollagenesis in a single in-office session. In the United States, the Viveve® System is cleared by the Food and Drug Administration (FDA) for use in general surgical procedures for electrocoagulation and hemostasis. International regulatory approvals and clearances have been received for vaginal laxity and/or improvement in sexual function indications in more than 50 countries.

Company profile

Ticker
VIVE
Exchange
Website
CEO
Scott C. Durbin
Employees
Incorporated
Location
Fiscal year end
Former names
PLC SYSTEMS INC
SEC CIK
IRS number
43153858

VIVE stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

13 May 21
2 Aug 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 28.45M 28.45M 28.45M 28.45M 28.45M 28.45M
Cash burn (monthly) (positive/no burn) (positive/no burn) 1.71M 1.48M 1.08M 1.06M
Cash used (since last report) n/a n/a 7.01M 6.08M 4.44M 4.36M
Cash remaining n/a n/a 21.44M 22.37M 24M 24.09M
Runway (months of cash) n/a n/a 12.5 15.1 22.1 22.7

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
23 Jun 21 Jim B Robbins Incentive Stock Option (Right to Purchase) Common Stock Grant Aquire A No No 2.73 104,700 285.83K 104,700
23 Jun 21 Morris Arlene NQSO Common Stock Grant Aquire A No No 2.73 51,700 141.14K 51,700
23 Jun 21 Scott Durbin Incentive Stock Option (Right to Purchase) Common Stock Grant Aquire A No No 2.73 655,300 1.79M 655,300
23 Jun 21 Debora Jorn NQSO Common Stock Grant Aquire A No No 2.73 51,700 141.14K 51,700
23 Jun 21 Sharon Collins Presnell NQSO Common Stock Grant Aquire A No No 2.73 39,000 106.47K 39,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

18.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 19 2 +850.0%
Opened positions 19 2 +850.0%
Closed positions 2 0 NEW
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 6.29M 1.9M +231.0%
Total shares 2M 403.99K +395.1%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Lincoln Park Capital Fund 701K $2.23M NEW
Empery Asset Management 675K $2.15M NEW
BLK Blackrock 295.42K $904K NEW
Vanguard 85.58K $262K NEW
Meitav Dash Investments 55K $168K NEW
VIRT Virtu Financial 43.16K $132K NEW
Citadel Advisors 29.51K $90K NEW
UBS UBS Group AG - Registered Shares 25.11K $77K NEW
Geode Capital Management 22.17K $67K NEW
GS Goldman Sachs 17.4K $53K NEW
Largest transactions
Shares Bought/sold Change
Lincoln Park Capital Fund 701K +701K NEW
Empery Asset Management 675K +675K NEW
BLK Blackrock 295.42K +295.42K NEW
Hudson Bay Capital Management 0 -240.99K EXIT
Alyeska Investment 0 -163K EXIT
Vanguard 85.58K +85.58K NEW
Meitav Dash Investments 55K +55K NEW
VIRT Virtu Financial 43.16K +43.16K NEW
Citadel Advisors 29.51K +29.51K NEW
UBS UBS Group AG - Registered Shares 25.11K +25.11K NEW

Financial report summary

?
Competition
HologicCuteraInmode
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: abatement, Aging, aimed, automatically, burn, comparison, Epidemiologic, exceeded, expansion, Impression, KIPO, leakage, maintenance, MESA, moderate, Modular, nearest, notification, percent, proportion, proportional, Remodeling, renowned, robust, shareholder, SMA, smooth, Social, sublandlord, thereof, TIPO, titled, underway, unissued, upsized, urine, USPTO
Removed: accurate, Acorn, adding, advertising, aesthetic, affirmative, agency, alter, Alternatively, analyzing, animal, approach, Asian, attribution, audit, balanced, bid, borrowed, bulletin, calendar, CE, CFB, charged, China, clinically, clinician, collected, committee, composite, comprising, confirmation, consecutive, consistency, consolidate, consultant, consulting, cooling, coverage, daily, Dalian, decline, decreased, deemed, deficiency, deliberate, delivery, demonstrating, Department, description, director, dispose, dose, Dynamic, earlier, effecting, electronic, eligible, enthusiastically, expanded, exploratory, Female, footprint, free, FSFI, furlough, generation, headcount, Hong, hosted, implemented, implementing, Importantly, increasing, Index, initiate, innovative, Instruction, intention, investor, Karen, kind, Kong, Korea, launch, leader, lender, LIBERATE, license, lien, limit, listed, listing, lost, Macau, mainland, Mark, media, Meditech, meeting, member, merge, milestone, momentum, monitor, multiple, national, nonemployee, notice, notifying, organization, OTC, overallotment, Paragon, participating, Pink, prepare, profile, proportionally, proposed, qualify, readout, regain, rendered, reposition, represent, repurchase, resignation, resigned, restructuring, resubmitted, RSA, Rule, score, secured, separable, shelf, shift, size, solicitation, South, statistical, statistically, sum, supplement, Taiwanese, thirty, threshold, topline, troubled, unchanged, undertaken, universal, unlisted, Urogenital, validated, vested, vivo, written, Zaderej